Shankara Building Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 10:14 pm

Competitors of Shankara Building Products Ltd

All Competitor Stocks of Shankara Building Products Ltd

Quarterly Result

Last Updated: August 1, 2025, 12:05 pm

Below is a detailed analysis of the quarterly data for Shankara Building Products Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,644.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,639.00 Cr. (Mar 2025) to 1,644.00 Cr., marking an increase of 5.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,585.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,588.00 Cr. (Mar 2025) to 1,585.00 Cr., marking a decrease of 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 8.00 Cr..
• For OPM %, as of Jun 2025, the value is 4.00%. The value appears strong and on an upward trend. It has increased from 3.00% (Mar 2025) to 4.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.36. The value appears strong and on an upward trend. It has increased from 11.73 (Mar 2025) to 13.36, marking an increase of 1.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:28 am

Growth

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: June 16, 2025, 11:23 am

Below is a detailed analysis of the balance sheet data for Shankara Building Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 24.00 Cr..
• For Reserves, as of Mar 2025, the value is 844.00 Cr.. The value appears strong and on an upward trend. It has increased from 773.00 Cr. (Mar 2024) to 844.00 Cr., marking an increase of 71.00 Cr..
• For Borrowings, as of Mar 2025, the value is 104.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 87.00 Cr. (Mar 2024) to 104.00 Cr., marking an increase of 17.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 701.00 Cr. (Mar 2024) to 830.00 Cr., marking an increase of 129.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,802.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,586.00 Cr. (Mar 2024) to 1,802.00 Cr., marking an increase of 216.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 297.00 Cr.. The value appears strong and on an upward trend. It has increased from 293.00 Cr. (Mar 2024) to 297.00 Cr., marking an increase of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,498.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,290.00 Cr. (Mar 2024) to 1,498.00 Cr., marking an increase of 208.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,802.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,586.00 Cr. (Mar 2024) to 1,802.00 Cr., marking an increase of 216.00 Cr..

Notably, the Reserves (844.00 Cr.) exceed the Borrowings (104.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Shankara Building Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 31.92. This value is within the healthy range. It has decreased from 34.67 (Mar 24) to 31.92, marking a decrease of 2.75.
• For Diluted EPS (Rs.), as of Mar 25, the value is 31.92. This value is within the healthy range. It has decreased from 34.67 (Mar 24) to 31.92, marking a decrease of 2.75.
• For Cash EPS (Rs.), as of Mar 25, the value is 38.79. This value is within the healthy range. It has decreased from 40.02 (Mar 24) to 38.79, marking a decrease of 1.23.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 357.86. It has increased from 328.89 (Mar 24) to 357.86, marking an increase of 28.97.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 357.86. It has increased from 328.89 (Mar 24) to 357.86, marking an increase of 28.97.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,349.15. It has increased from 1,991.11 (Mar 24) to 2,349.15, marking an increase of 358.04.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 71.00. This value is within the healthy range. It has increased from 64.47 (Mar 24) to 71.00, marking an increase of 6.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 64.13. This value is within the healthy range. It has increased from 57.91 (Mar 24) to 64.13, marking an increase of 6.22.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.58. This value is within the healthy range. It has decreased from 44.58 (Mar 24) to 42.58, marking a decrease of 2.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 31.92. This value is within the healthy range. It has decreased from 33.45 (Mar 24) to 31.92, marking a decrease of 1.53.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 31.92. This value is within the healthy range. It has decreased from 33.45 (Mar 24) to 31.92, marking a decrease of 1.53.
• For PBDIT Margin (%), as of Mar 25, the value is 3.02. This value is below the healthy minimum of 10. It has decreased from 3.23 (Mar 24) to 3.02, marking a decrease of 0.21.
• For PBIT Margin (%), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 10. It has decreased from 2.90 (Mar 24) to 2.72, marking a decrease of 0.18.
• For PBT Margin (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 10. It has decreased from 2.23 (Mar 24) to 1.81, marking a decrease of 0.42.
• For Net Profit Margin (%), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 5. It has decreased from 1.68 (Mar 24) to 1.35, marking a decrease of 0.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 8. It has decreased from 1.68 (Mar 24) to 1.35, marking a decrease of 0.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 15. It has decreased from 10.17 (Mar 24) to 8.91, marking a decrease of 1.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.66. This value is within the healthy range. It has increased from 17.07 (Mar 24) to 17.66, marking an increase of 0.59.
• For Return On Assets (%), as of Mar 25, the value is 4.29. This value is below the healthy minimum of 5. It has decreased from 5.11 (Mar 24) to 4.29, marking a decrease of 0.82.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has increased from 0.10 (Mar 24) to 0.11, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 3.36. There is no change compared to the previous period (Mar 24) which recorded 3.36.
• For Current Ratio (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 1.67 (Mar 24) to 1.60, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 1.03 (Mar 24) to 0.97, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 4. It has increased from 2.11 (Mar 24) to 2.52, marking an increase of 0.41.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 9.39. This value is below the healthy minimum of 20. It has increased from 7.03 (Mar 24) to 9.39, marking an increase of 2.36.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.72. This value is below the healthy minimum of 20. It has increased from 5.88 (Mar 24) to 7.72, marking an increase of 1.84.
• For Earning Retention Ratio (%), as of Mar 25, the value is 90.61. This value exceeds the healthy maximum of 70. It has decreased from 92.97 (Mar 24) to 90.61, marking a decrease of 2.36.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.28. This value exceeds the healthy maximum of 70. It has decreased from 94.12 (Mar 24) to 92.28, marking a decrease of 1.84.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.30. This value is within the healthy range. It has decreased from 4.83 (Mar 24) to 3.30, marking a decrease of 1.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 3. It has decreased from 3.51 (Mar 24) to 2.48, marking a decrease of 1.03.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,445.40. It has decreased from 1,603.80 (Mar 24) to 1,445.40, marking a decrease of 158.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 24) to 0.25, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 10.26 (Mar 24) to 8.39, marking a decrease of 1.87.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 1. It has decreased from 0.32 (Mar 24) to 0.24, marking a decrease of 0.08.
• For Retention Ratios (%), as of Mar 25, the value is 90.60. This value exceeds the healthy maximum of 70. It has decreased from 92.96 (Mar 24) to 90.60, marking a decrease of 2.36.
• For Price / BV (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.58, marking a decrease of 0.37.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 1. It has decreased from 0.32 (Mar 24) to 0.24, marking a decrease of 0.08.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness